Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Should we be targeting triglyceride as well as LDL cholesterol in the battle against coronary heart disease?

Nature Clinical Practice Cardiovascular Medicine volume 5, pages 438–439 (2008)Cite this article

boxed-textMiller M et al. (2008) Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial. J Am Coll Cardiol 51: 724–730

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Cannon CP et al. (2004) Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 350: 1495–1504

    Article  CAS  Google Scholar 

  2. Assmann G (2001) Pro and con: high density lipoprotein, triglycerides, and other lipid subfractions are the future of lipid management. Am J Cardiol 87: 2B–7B

    Article  CAS  Google Scholar 

  3. British Cardiac Society; British Hypertension Society; Diabetes UK; HEART UK; Primary Care Cardiovascular Society; Stroke Association (2005) JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice Heart 91 (Suppl 5): v1–v52

  4. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Adult Treatment Panel III: final report. National Institutes of Health. National Heart, Lung, and Blood Institute. NIH publication No. 02-5215. September 2002

Download references

Acknowledgements

The synopsis was written by Alexandra King, Associate Editor, Nature Clinical Practice.

Author information

Author notes

  1. Glasgow Clinical Research Facility, Tennent Building, Western Infirmary, 38 Church Street, Glasgow G11 6NT, UK allan.gaw@ggc.scot.nhs.uk

Authors and Affiliations

  1. A Gaw is Director of the Glasgow Clinical Research Facility, Glasgow, UK.,

    Allan Gaw

Authors
  1. Allan Gaw
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gaw, A. Should we be targeting triglyceride as well as LDL cholesterol in the battle against coronary heart disease?. Nat Rev Cardiol 5, 438–439 (2008). https://doi.org/10.1038/ncpcardio1249

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpcardio1249

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing